Both NAD injections and IV therapy are effective delivery methodsbut they serve slightly different purposes depending on your lifestyle and wellness priorities
Trulicity (dulaglutide) and Ozempic (semaglutide) are GLP-1 agonists used to manage type 2 diabetes, with Ozempic generally considered more effective for lowering blood sugar and boosting weight loss
GLP-1 receptor agonists, the drug class that includes semaglutide (sold as Ozempic and Wegovy), appear to reduce cravings, lower overdose risk and decrease substance use disorder diagnoses in real-world studies
Despus de al menos 4 semanas con 0,5 mg, sta se puede incrementar hasta 1,0 mg una vez a la semana, para lograr as, una nueva mejora del control glucmico[4]
The diabetes and weight loss drug Tirzepatide sold as Mounjaro and Zepbound, respectively significantly improved heart failure symptoms and related physical limitations in a Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, has shown promise in the treatment of type 2 diabetes and obesity
Studies were selected based on relevance to obesity treatment, clarity of reported outcomes, and applicability to metabolic and weight-related endpoints
